Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells
- PMID: 1691604
- DOI: 10.1164/ajrccm/141.4_Pt_1.960
Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells
Abstract
Upon activation by most stimuli, basophils and human lung mast cells simultaneously release histamine and arachidonic acid metabolites. Hyperosmolar activation was examined, and both cell types were shown to release histamine but little or no leukotriene C4 or D4 (LTC4/D4) and, in the case of mast cells, little or no prostaglandin D2 (PGD2). In addition, hyperosmolar buffers were capable of preventing the formation of LTC4/LTD4 in basophils stimulated by anti-IgE when added simultaneously, or 2, 5, or 10 min after, the addition of anti-IgE. Catabolism of PGD2 and LTC4/D4 was not increased. Experiments with cell lysates demonstrated that intracellular formation, rather than secretion, was arrested in hyperosmolar buffers. We conclude that this selective inhibition of mediator production is a unique response of mast cells and basophils to osmotic activation. Although the mechanism of this selective cellular response is not clear, these in vitro observations have important therapeutic and pathophysiologic implications for the airway response to hyperosmolar stimuli.
Similar articles
-
Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.J Pharmacol Exp Ther. 1988 Oct;247(1):209-17. J Pharmacol Exp Ther. 1988. PMID: 2459368
-
Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells.J Immunol. 1988 Mar 15;140(6):1953-7. J Immunol. 1988. PMID: 2450136
-
The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.J Immunol. 1992 Jul 15;149(2):599-608. J Immunol. 1992. PMID: 1378071
-
Mediator release from human basophils and mast cells from lung and intestinal mucosa.Int Arch Allergy Appl Immunol. 1985;77(1-2):130-6. doi: 10.1159/000233767. Int Arch Allergy Appl Immunol. 1985. PMID: 2409011 Review. No abstract available.
-
Studies with purified human basophils and mast cells.Monogr Allergy. 1983;18:259-64. Monogr Allergy. 1983. PMID: 6196631 Review. No abstract available.
Cited by
-
A case report of food-dependent exercise-induced anaphylaxis (FDEIA) treated with omalizumab.Front Allergy. 2024 Oct 11;5:1472320. doi: 10.3389/falgy.2024.1472320. eCollection 2024. Front Allergy. 2024. PMID: 39464254 Free PMC article.
-
Long-term omalizumab use in the treatment of exercise-induced anaphylaxis.Allergy Rhinol (Providence). 2017 Oct 1;8(3):170-172. doi: 10.2500/ar.2017.8.0204. Allergy Rhinol (Providence). 2017. PMID: 29070274 Free PMC article.
-
Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment.Front Physiol. 2012 Dec 10;3:460. doi: 10.3389/fphys.2012.00460. eCollection 2012. Front Physiol. 2012. PMID: 23233839 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous